All of this indicated that the core breast ER-status signature (Figure 2) was a pattern of ER-, HER2- breast cancer, with the ER-, HER2+ breast cancers having a different pattern, as has been indicated in previous expression profiling studies [6,7,12]. This evidence concerns the gene ERBB2 and breast carcinoma.